BusinessUS Waives Tariffs on Specialty Drugs Affecting India
The US has announced zero tariffs on certain specialty pharmaceutical products and ingredients, including orphan drugs, nuclear medicines, and gene therapies, benefiting India among other countries. This follows President Trump's April 2 announcement to adjust pharmaceutical imports and boost domestic production. While some tariffs under Section 232 took effect from July 31 and September 29, generic drugs from India remain exempt, providing relief to the Indian pharmaceutical sector.
News18·3h ago



